Back to Browse Journals » Patient Preference and Adherence » Volume 2

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia

Authors Haya Ascher-Svanum, Baojin Zhu, Douglas E Faries, Jonathan P Lacro, Christian R Dolder, Xiaomei Peng

Published 13 March 2008 Volume 2008:2 Pages 67—77


Haya Ascher-Svanum1, Baojin Zhu1, Douglas E Faries1, Jonathan P Lacro2, Christian R Dolder3, Xiaomei Peng1

1Eli Lilly and Company, Outcomes Research, Indianapolis, IN, USA; 2VA San Diego Health Care System and Department of Psychiatry, University of California, San Diego, CA, USA; 3Wingate University School of Pharmacy, Wingate, NC, USA

Objective: To compare adherence and persistence to typical versus atypical antipsychotics and between specific atypical agents in the usual care of schizophrenia and to examine the association between adherence and persistence.

Method: Data were drawn from a 3-year prospective, nonrandomized, noninterventional study of schizophrenia conducted during 1997–2003. Initiators on haloperidol, risperidone, olanzapine, quetiapine, and clozapine with at least 1 year of follow-up were included (n = 878). Adherence (Medication Possession Ratio, MPR) and persistence (time to all-cause medication discontinuation) were assessed using medical record prescription information. Analyses employed multivariate statistics adjusted for group differences.

Results: Overall, 58% of the patients were deemed adherent (MPR >80%). Adherence rates were higher: for atypical (59.4%) than typical antipsychotics (34.5%, p < 0.001), for clozapine (77%) than each comparator excluding olanzapine (p < 0.01), and for olanzapine (64%) than risperidone (57%, p = 0.027) and quetiapine (52%, p = 0.019). Differences between risperidone and quetiapine were not statistically significant. Adherence and persistence were highly correlated (r = 0.957, p < 0.001).

Conclusion: In the usual care of schizophrenia, medication adherence and persistence appear to be highly correlated and to significantly differ between typical and atypical antipsychotics and among atypical agents. The choice of antipsychotic may play a meaningful role in patients’ adherence to and persistence with antipsychotic medications.

Keywords: adherence, persistence, schizophrenia, antipsychotics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K

Neuropsychiatric Disease and Treatment 2012, 8:113-118

Published Date: 15 March 2012

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al

ClinicoEconomics and Outcomes Research 2011, 3:9-14

Published Date: 11 January 2011

Readers of this article also read:

Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines

Alvarez-Berríos MP, Castillo A, Rinaldi C, Torres-Lugo M

International Journal of Nanomedicine 2014, 9:145-153

Published Date: 20 December 2013

Retrospective review of bone mineral metabolism management in end-stage renal disease patients wait-listed for renal transplant

Chavlovski A, Knoll GA, Ramsay T, Hiremath S, Zimmerman DL

Transplant Research and Risk Management 2012, 4:25-30

Published Date: 5 September 2012

Current and emerging treatments for uterine myoma – an update

Duhan N

International Journal of Women's Health 2011, 3:231-241

Published Date: 8 August 2011

Role of glutathione in immunity and inflammation in the lung

Pietro Ghezzi

International Journal of General Medicine 2011, 4:105-113

Published Date: 25 January 2011

Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent

Peter Reimer, Rolf Vosshenrich

Biologics: Targets and Therapy 2010, 4:199-212

Published Date: 4 August 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009